Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses.

Li ZN, Weber KM, Limmer RA, Horne BJ, Stevens J, Schwerzmann J, Wrammert J, McCausland M, Phipps AJ, Hancock K, Jernigan DB, Levine M, Katz JM, Miller JD.

J Virol Methods. 2017 May;243:61-67. doi: 10.1016/j.jviromet.2017.01.008. Epub 2017 Jan 17.

PMID:
28108183
2.

The effect of viral suppression on cross-sectional incidence testing in the johns hopkins hospital emergency department.

Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, Kraus CK, Shahan J, Kelen GD, Quinn TC.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):211-5. doi: 10.1097/QAI.0b013e3181743980.

3.

Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans.

Laeyendecker O, Henson C, Gray RH, Nguyen RH, Horne BJ, Wawer MJ, Serwadda D, Kiwanuka N, Morrow RA, Hogrefe W, Quinn TC.

J Clin Microbiol. 2004 Apr;42(4):1794-6.

4.

The use of prophylactic eye drops during high-dose cytosine arabinoside therapy.

Higa GM, Gockerman JP, Hunt AL, Jones MR, Horne BJ.

Cancer. 1991 Oct 15;68(8):1691-3.

PMID:
1913509
5.

Adoptive transfer and specific active immunization of patients with malignant melanoma.

Seigler H, Buckley CE, Sheppard LB, Horne BJ, Shingleton WW.

Ann N Y Acad Sci. 1976;277(00):522-32. No abstract available.

PMID:
1069561

Supplemental Content

Loading ...
Support Center